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Diabetes mellitus is often cited as a metabolic disease that depresses the anti- 
bacterial defenses of the host (1). Many clinical investigators have reported that 
patients with uncontrolled diabetes are unusually susceptible to bacterial dis- 
eases, particularly of staphylococcal etiology (2). Attempts to confirm this rela- 
tionship experimentally, however, have been only partially successful. 
No impairment of immunological  competence has been detected in diabetic 
patients (3), and deficiencies in cellular defense have been demonstrated only in 
the presence of ketoacidosis (4-6), even though an insulin-correctable depression 
of glycolysis has been noted in the leukocytes of nonacidotic diabetics (7, 8). 
Similar results have been reported in animals with diabetes induced by pancrea- 
tectomy or treatment with ailoxan;  i.e.,  only when the relatively complicated 
metabolic and circulatory derangements of ketoacidosis have been present, has 
increased susceptibility to bacter';al (9) and mycotic (10) infections been consist- 
ently demonstrated.  Although nonacidotic rats with chronic alloxan  diabetes 
have been reported to be more susceptible to experimental staphylococcal peri- 
tonitis than nondiabetic rats (11), no such difference was demonstrable in either 
mice (12) or rabbits (9). 
The present studies were undertaken in order to determine experimentally 
whether chronic hyperglycemia per se impairs  antibacterial resistance and to 
define the mechanism involved, if it does so. 
In Vivo Experiments 
Choice of Animal Modd.--Male albino rats weighing 160 to 200 gl were used in all experi- 
ments because of (a) the ease with which they are made chronically diabetic with alloxan (13), 
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and  (b)  the extent to which their  responses have  been studied  in experimentally induced 
bacterial infections (14). 
Alloxan monohydrate 2 was injected subcutaneously in a dose of 200 mg per kg of body 
weight. The animals were allowed Rockland mouse-rat pellets  3 and water ad lib., both before 
and after  the injection. Within 24 hr,  they developed ruffled fur,  polydipsia, polyphagia, 
diarrhea,  polyuria,  glycosuria, and  ketonuria.  Whereas  the  polydipsia,  polyuria,  hyper- 
glycemia (300 to 900 rag/100 ml),  4 and glycosuria persisted, the ketonufia subsided on about 
the 4th day. 5 Approximately 25% of the injected animals died within the 1st wk; the survivors 
usually lost 20 g in weight during the next 2 wk, and thereafter gained weight more slowly 
than controls. Infection was not induced until the ketonuria had subsided and hyperglycemia 
(>300 rag/100 ml) and a heavy glycosuria (4A-) had persisted for at least 3 wk. 
On account of the data already available on its pathogenesis (14), pneumococcal  pneumonia 
was selected for study in the diabetic rats. The infecting organisms, suspended in 10% mucin, 
were inoculated intrabronchially under light ether anesthesia.  6 When the pneumonia was thus 
produced with a highly virulent strain of Type 1 pneumococci, all of the nondiabetic animals 
died from even a minimal inoculum. Conversely, when an organism of very low virulence, 
e.g. Eschcrichia coli,  was injected in maximum doses, barely discernible lesions were produced. 
Accordingly, a bacterial strain of intermediate virulence was sought that would kill all of the 
control animals at high dosage and none of them at low dosage. These criteria were met by a 
Type 25 pneumococcus, kindly  provided by Dr. Robert Austrian of the University of Pennsyl- 
vania. 
Mortality Studies.--As shown in Text-fig.  1,  the  cumulative mortalities in 
the diabetic rats at each of four intrabronchial doses of Type 25 pneumococci 
were significantly higher than in the nondiabetic rats. In addition, the LDs0 in 
the  diabetic  group  was  less  than  one  twentieth  of  that  in  the  nondiabetic 
group. 
Bacterial Counts in Lesions.--Since neither ketonuria nor a significant  increase 
in hyperglycemia developed  in the  diabetic animals during the  infection, it 
seemed unlikely that the mortality differences were due solely to an exacerba- 
tion of the diabetes. To determine whether a loss of antibacterial resistance was 
involved, the kinetics of bacterial growth in the pulmonary lesions were com- 
pared  in the  two  groups  (Text-fig. 2).  The  average numbers of viable pneu- 
mococci in the lesions of the diabetic animals at 24 and 36 hr were nearly ten 
times as great as in the nondiabetics. 
ttistologic Observations.--Further evidence that the antibacterial defenses of 
the diabetic rats were compromised is presented in Fig. 1. Histologic examina- 
tions of the 24- and 36-hr lesions revealed many more bacteria and much less 
phagocytosis in the diabetic animals than in the controls. Inasmuch as the blood 
Mann Research Laboratories, Inc., New York. 
3  Teklad, Inc., Monmouth, Illinois. 
4 All glucose levels were measured by the glucose oxidase method (15). 
5 Blood pH determinations also revealed that there was no persistent acidosis. 
6The granular mucin  (Type  1701, Wilson Laboratories,  Chicago) was added  to 0.15 M 
NaC1, and the mixture was autoclaved and brought to pH 7.4 with 1 N NaOH. Details of the 
methods used in handling the cultures, producing the pneumonia, and following its progress 
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leukocyte counts were, if anything, higher in the diabetic than in the nondia- 
betic animals (Table I), it was assumed that the overgrowth of bacteria in the 
diabetic lesions was not due to an inadequate supply of circulating leukocytes. 
Indeed, the histologic findings indicated no impairment of the inflammatory re- 
sponse in the diabetic animals, but rather a  failure of the mobilized leukocytes 
to ingest the invading organisms. 
Intraperitoneal Phagocylosis.--The apparent depression of phagocytic activ- 
ity was confirmed in the following experiment. 
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TZxT-FIo.  1. Comparative  dose response curves  of diabetic  and  nondiabetic  (normal) 
rats  inoculated intrabronchially  with Type 25 pneumococei suspended in  mudn. Ten rats  in 
each  group were inoculated  at each dosage  level,  except at l0  s  and 107  where only 5 rats  in 
each group were inoculated.  All  deaths occurred within 5 days. The I.Us0  calculated  by the 
Reed-Muench method (17,  18)  was 5 X  108  for  the  diabetic  animals  and  9 X  104  for  the  non- 
diabetic.  A statistical  test  (19)  comparing  the  weighted  mean differences  in  mortality  at  the  4 
intermediate dosage  levels  indicated  differences  in  mortality  significant  at the  0.01% level. 
Acute peritonitis  was produced in both diabetic and nondiabetic rats by the injection of 
5 ml of autoclaved 3% starch and 5% aleuronat solution diluted 1:1 with tryptose phosphate 
broth (20). After 20 hr such induced exudates were found in the nondiabetic rats to contain 
0.9 to 1.2 X  108 leukocytes (ca. 70% graaulocytes) and in the diabetic rats to contain  1.9 to 
2.0 X  los leukocytes.  To keep  the multiplicity  of cells to pneumococci approximately  the 
same in both sets of 20-hr exudates (21), the number of pneumococci injected intraperitoneally 
in the two groups of rats was 8 X  108 and 16 X  l0  s respectively.  7 30 rain later each rat was 
killed with chloroform and its peritoneal exudate was removed, concentrated by centrifugation 
in the cold (150 g for 5 rain), and stained with methylene blue. 
The comparative phagocytic indices obtained clearly showed an impairment 
of phagocytosis in the exudates of the diabetic animals  (Table II). 
7 The organisms were injected into each animal in 0.5 ml of broth. 230  DIABETES  AND  ANTIBACTERIAL  DEFENSE 
In Vitro Experiments 
From the collective results of the foregoing in vivo experiments it was con- 
cluded that chronically hyperglycemic, nonacidotic, diabetic rats are less resist- 
ant to acute pneumococcal pneumonia than nondiabetic rats, and that the low- 
ered resistance is due primarily to a defect in the phagocytic defense. In vitro 
experiments were therefore undertaken to investigate the nature of this defect. 
Design of Phagocytic Test.--The results of in vitro phagocytic tests are often 
misleading because the conditions under which the cells must operate are not 
similar enough to the conditions that obtain in vivo. One of the most frequent 
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TracT-Fro.  2.  Comparative numbers of viable pneumococci in pneumonic lesions of non- 
diabetic (open columns) and diabetic rats (solid columns) sacrificed 12, 24, and 36 hr after 
intrabronchial inoculation. All lesions were confined to the left lung, which was removed en 
bloc by sterile techniques, ground in a  mortar with sterile sand and 9 ml of trypticase soy 
broth, and diluted in 10-fold increments with broth for counting by the pour plate technique. 
The statistical significance of the difference noted in the two groups of animals at each time 
interval is indicated by the P  value recorded above the columns. 
dissimilarities relates to the amount of fluid in the system; most in vitro prep- 
arations of cells and bacteria are far more dilute  than infected inflammatory 
exudates in the host (14,  22).  The phagocytic test used in the present studies 
was therefore designed to simulate as closely as possible a concentrated inflam- 
matory exudate (21,  22). 
Pneumococci harvested from 4-hr cultures in serum-beef infusion broth (21) were washed 
twice in cold HBG,  s concentrated by ceutrifugation, counted in a  Petroff-Hausser counting 
chamber, and diluted in  HBG to  the point where each 0.025  ml of suspension contained 
20 X  l0  s pneumococci. Leukocytes were obtained from acute peritoneal exudates induced in 
rats by the starch-aleuronat method already described. After 21 hr each rat was killed with 
8Modified  Hanks'  solution  (120n~  NaCI,  10.1 m~  KC1,  5.6m~  Na~HPO4, 0.9  n~ 
KH~PO4,  2.9  m~ K~I-IPO4) containing 0.01%  crystalline bovine serum albumin and 0.1% 
glucose (23). R.  H.  DRACttMAN,  R.  K.  ROOT,  AND  W.  B.  WOOD,  JR.  231 
chloroform, its abdominal cavity was opened, and the exudate was removed with 15 to 25 ml 
of cold H.BG containing 0.005~o heparin. The exudates from several rats were pooled, and the 
cells were centrifuged twice in HBG at 150 g for 5 rain. Aliquots containing 2.5 X  108 cells 
were centrifuged, the supernatant was decanted as completely as possible,  and 0.025 m_l of the 
bacterial suspension  and  0.1  ml of fresh rat  serum were added  to the packed  cells.  After 
thorough mixing, 0.03 ml of the combined suspension was spread evenly over an area of 1 X  2 
cm on a glass slide and incubated for 30 rain at 37°C in a sealed Petri dish lined with moistened 
TABLE  I 
Comparative Blood Leukocyte Counts* in Diabetic and Nondiabetic Rats with 
Type g5 Pneumococcal Pneumonia 
Metabolic state 
Diabetic 
Nondiabetic 
Rat No. 
2hr 
9,100 
7,200 
8,300 
14,100 
7,500 
8,800 
7,500 
13,900 
Time after inoculation 
10 hr 
20,800 
15,800 
21,500 
23,800 
15,600 
11,100 
13,800 
10,400 
24 hr 
2,600 
2,100 
4,900 
10,200 
4,400 
2,300 
2,700 
3,000 
* Counts made on blood from tail. 
TABLE II 
In Vivo Phagooytosis of Type 25 Pneumococci in Preformed Peritoneal 
Exudates of Diabetic and Nondiabegic Rags 
Metabolic state  Phagocytosis* 
% 
Diabetic  44,  38,  39,  44 
Nondiabetic  75,  73,  79,  81 
*  Each count was made on the exudate of a different animal. Multiplicity of cells to pneu- 
mococci in exudates ~  1:8. 
filter paper. The mixture was then washed from the slide with cold HBG and centrifuged at 
80 g for 3 rain. Most of the unphagocytized bacteria remained in the supernate, which was 
discarded. Smears made from the centrifugate were air-dried and stained with methylene blue. 
The percentage of cells containing one or more ingested pneumococci (per cent phagocytosis) 
was determined by counting 400 to 600 cells. 
Demonstration  of Defect in Serum.--Since polymorphonuclear leukocytes de- 
rive energy for phagocytosis from the metabolism of glucose (24), and since gly- 
colysis has been found to be depressed in the granulocytes of diabetic patients 232  DIABETES  AND  ANTIBACTERIAL  DEFENSE 
(7), it was presumed a priori that the factor impairing phagocytosis in the chron- 
ically diabetic rats would be found in the cells rather than in the serum.  That 
this was not the case, however, is shown in Table III. In normal rat serum, the 
phagocytic activity of leukocytes from the diabetic rats was just as great as that 
of leukocytes from the nondiabetic controls. In the diabetic rat serum,  on the 
TABLE HI 
In Vitro Pkagocytosis of Type 25 Pneumococci in Serum-Call Systems from 
Diabetic and Nondiabe~ Rats 
Incubation  medium 
Exudate leukocytes 
Nondlabetic serum  Diabetic serum 
From nondiabetic rats  75.6  (±3.6)*  54.8  (±7.0)* 
From diabetic rats  76.0  (±3.8):I  57.8  (±6.3)~ 
* Mean per cent phagocytosis (± sD) in 4 experiments. 
Mean per cent phagocytosis (± sn) in 5 experiments. 
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TExT-Fro. 3.  Effect of increasing concentrations  of glucose on in vitro phagocytosis of 
Type 25 pneumococci in concentrated  serum-leukocyte  suspensions. Open  circles refer  to 
preparations  contaiuing nondiabetic  serum  to which extra  glucose was added;  solid circles 
refer  to comparable  preparations  containing  diabetic  serum.  Bars  indicate ±  1 standard 
deviation of per cent phagocytosis. 
other hand, phagocytosis by both the normal and the diabetic leukocytes was 
depressed.  Similarly, the serum from the diabetic rats was found to impair the 
motility of both the normal and the diabetic cells (Fig. 2). 
Identification of Depressive Factor.--The combined results of the following two 
experiments indicate that the depressive factor in the diabetic serum was its ab- 
normally high content of glucose. 
1. Using leukocytes and serum from nondiabetic rats,  phagocytic tests  were 
performed in which increasing concentrations of glucose were added to the se- R.  H.  DRACHMAN,  R.  K.  ROOT~ AND  W. B.  WOOD~ JR.  233 
rum. As shown in Text-fig. 3, the depression of phagocytosis that resulted was 
approximately  equal  to that  caused by diabetic  serum  containing  about  the 
same amount of glucose. 
2. To make certain that the  glucose,  rather  than  some other  component of 
the diabetic  serum,  was the primary factor involved,  different aliquots of the 
same lot of diabetic serum were dialyzed against normal nonhyperglycemic se- 
rum and normal serum which had beeu made hyperglycemic by the addition of 
glucose. The results recorded in Table IV show that dialysis against the nonhy- 
perglycemic serum removed most, if not all, of the depressive factor from the 
diabetic serum, whereas dialysis against the hyperglycemic serum removed none 
of it. 
TABLE IV 
Effect on Phagocytosis* oJ Removing Glucose  fiom Diabetic Serum by Dialysis 
Final glucose  No. of  Phagocytosis (-4- SD)  Serum in phagocytic test  concentrations  experiments 
Nondiabetic 
Diabetic, undialyzed 
Diabetic, dialyzed vs. normal  serum~ 
Diabetic, dialyzed vs. hyperglycemic 
serum§ 
mg/  lO0 nd 
156 
821 
185 
911 
% 
65.5  (±4.7) 
38.3  (±0.7) 
6o.0 (±6.6) 
28.s  (±8.o) 
* Of type 25 pneumococcus. 
:~ 1 ml of diabetic serum was dialyzed for 20 hr at 4°C against 2 changes of 10 ml each of 
normal serum containing  156 rag/100  ml of glucose. 
§ Dialyzed in same manner against normal serum to which glucose had been added to make 
a  final  concentration  of 944  rag/100  ml. 
Clearly the principal depressive factor in the diabetic serum was its high con- 
tent of glucose. 
Mechanism  of Glucose Effect.--Since  the  glucose depressed  phagocytosis of 
normal and diabetic leukocytes to about the same degree (Table III), it seemed 
unlikely that the effect was due to a direct interference with energy metabolism. 
The phagocytic activity of granulocytes is known, on the other hand, to be im- 
paired in hypertonic media (26-29). The possibility that the hyperosmolarity of 
the hyperglycemic serum was responsible for the depression of phagocytic ac- 
tivity was therefore tested. 
To individual samples of pooled normal rat serum different sugars were added to make the 
final concentration  of total sugar  9 in each sample 43 raM, i.e. the equivalent  of 775 rag/100 
ml of glucose. The sugars added  were glucose, fructose,  sucrose, mannose, arabinose,  and 
xylose. At least the last two of these are not metabolized by granulocytes (30). 
9 Endogenous plus exogenous; see Table V. 234  DIABETES  AND  ANTIBACTERIAL  DEFENSE 
All  of  the  sugars  depressed  the  phagocytosis  of  pneumococci  in  vitro  to 
about the same extent (Table V), suggesting that their effect on the leukocytes 
was osmotic rather  than metabolic. 
Limitations  of Glucose  Effect.--When  the  phagocytic  tests  were  performed 
using a  more dilute system in which the same number of exudate leukocytes as 
TABLE V 
Pkagocytosis of Type 25 Pneumococcus in Normal Serum Made Hypertonic 
with Various Sugars 
Sugar added*  Phagocytosis 
Glucose 
Fructose 
Sucrose 
Mannose 
Xylose 
Arabinose 
% 
72  (±3.5)§ 
40,  36,  45ll 
46,  40,  52 
50,  50 
47,  47 
44,  46 
50,  50,  48,  50,  47 
* To make final concentration of total  sugar 43 n~. 
:~ Endogenous glucose ca. 10 m~t (180 mg/100 ml). 
§ Standard  deviation of mean for 10 experiments. 
[[ Each figure is from a different experiment. 
TABLE VI 
In ViZro Phagocytosis of Type 25 Pneumococci in Dil~e Phagocytic System* 
Serum  Sugar added~  Phagocytosis 
% 
Normal  --  76,  78,  75§ 
"  Glucose  70,  73,  77 
"  Sucrose  70,  80 
* The same number of leukocytes (2.5  X  I0  s) and one fourth the number of bacteria (5 
X  10  s) were used as in the standard concentrated system (Tables II to V), and  the volume 
of serum in which they were suspended was 1.0 ml rather than 0.1  ml. Tubes were rotated 
end-over-end at  12  moxt for 30  min  at  37°C. 
To make final concentrations of total sugar 43 m~ (see Table V). 
§ Each  figure indicates  the result  of a  different experiment. 
in the concentrated system were suspended in 1 ml (instead of 0.1 ml) of serum 
in a  closed tube rotated end-over-end for 30 rain at  12 RPM and 37°C, 1° neither 
10 Unless the mixture is agitated to increase the contacts of bacteria with leukocytes, very 
little phagocytosis occurs in such a dilute system (21). With agitation in this volume of serum 
(1.0 ml), however, the per cent phagocytosis in the control is >90%.  Since at this maximal 
level of phagocytosis, the test is relatively insensitive to minor changes in phagocytic function, R.  H.  DRACHM.AN, R.  K.  ROOT,  AND  W.  B.  WOOD,  JR.  235 
TABLE  VII 
In Vitro Phagocytosis of Type 25 Pneumococci in Normal and 
Hyperglycemic Rog Blood* 
Multiplicity of 
Blood  pneumococci to  No. of  leukocytes  experiments  Phagocytosis  (-4- sv) 
Normal~ 
Glucose added§ 
Diabetic]l 
Normal 
Glucose added 
8:1 
8:1 
8:1 
1:1 
1:1 
% 
92.7  (-4-2.4) 
95.2  (-4-1.3) 
95.5  (+0.8) 
47.9  (=t=3.4) 
44.3  (+1.7) 
* I ml of heparinized whole blood, to which pneumococoi were added at the pneumoenccus- 
leukocytic multiplicities indicated, were rotated end-over-end at 12 m,M for 30 rain at 37°(2. 
Counts were made as in other phagocytic tests  (see text). 
Range of glucose concentrations 95 to 157 rag/100 ml. 
§ Range of glucose concentrations 505  to  757  rag/100 ml. 
[[ Glucose  concentration  505  mg/100  ml. 
TABLE  VIII 
In Vitro Phagocytosis of Unencapsulated (R) Pneumococci* in Normal 
and Hyperglycemic Rat Serum~ 
Multiplicity of pneumococci 
to leukocytes 
8:1 
4:1 
2:1 
1:1 
Normal serum§ 
95,  94 
77,  75 
67,  64 
50,  54 
Phagoccytosis 
Hyperglycemic seruml[ 
92,  96 
70,  72 
63,  64 
56,  47 
* Strain R36NC (21). 
Standard concentrated system  (see text and Tables II to V), 
§ Range of glucose concentrations 198  to  208  rag/100 ml. 
[[ Range of glucose concentrations 684 to 772 rag/100 ml. 
glucose nor sucrose added  to the serum  (as in the preceding  experiment)  de- 
pressed the phagocytosis (Table VI). Likewise, in analogous experiments done 
with whole blood, the per cent phagocytosis was depressed only slightly, if at all, 
in blood to which glucose had been added (Table VII) ; and finally, even in the 
original  concentrated  system coutaining  exudate leukocytes,  serum  to which 
the multiplicity of bacteria to cells was decreased from 8:1 to 2:1. This change lowered the 
per cent phagocytosis to the same sensitive range (ca. 70%) that obtained in the tests per- 
formed with the standard concentrated system (Tables II to V). 236  DIABETES  AND  ANTIBACTERIAL  DEFENSE 
glucose had been added failed to exert a significant depressive effect when the 
encapsulated Type 25 pneumococci were replaced by a more easily phagocy- 
tized unencapsulated (R) strain of the same species  (Table VIII). 
These findings indicate that the depressive action of the hyperglycemic serum 
can be clearly demonstrated in vitro only under conditions that (a) simulate the 
cellular crowding of full-blown inflammatory exudates, and (b) extend the phag- 
ocytic capabilities of the cells (see Discussion). 
DISCUSSION 
Impairment of antibacterial defense is most likely to be detected when the 
host-parasite relationships are in a state of delicate balance. The type of bac- 
terial disease selected for study, be it naturally acquired or experimental, is 
therefore critical. In the present experiments a model bacterial disease was em- 
ployed in which it was possible,  by varying the infecting dose, to achieve the 
necessary balance between the host and the organism. Under these conditions, 
the depressive effect of prolonged hyperglycemia on the defenses of the host was 
readily demonstrated. Failure of others (9, 10, 12) to observe the effect in exper- 
imental infections was doubtless due to the nature of the model studied. 
Evidence was obtained both in vivo and in vitro that the phagocytic capabil- 
ities of polymorphonuclear leukocytes are affected by the high levels of glucose 
in the tissues of chronically diabetic rats. In the intact diabetic animal, not only 
did the histological and quantitative bacteriological findings suggest a depres- 
sion of phagocytosis, but an impairment of in vivo phagocytic activity was also 
demonstrated in a preformed inflammatory exudate. The latter finding was of 
particular significance, since it indicated that the relationships between high 
glucose levels and phagocytosis, that were defined more precisely in vitro, were 
also applicable in vivo. 
Although phagocytosis by granulocytes has long been known to be impaired 
in hypertonlc media (26--29), the degree of hypertonicity required to produce 
the effect has usually been somewhat larger (40 to 100 milliosmols) than that 
provided by the hyperglycemic serum (ca.  10 to 40 milliosmols). The cells em- 
ployed in these earlier studies, however, were not subjected to the kind of phag- 
ocytic stress  that was investigated in the present experiments, where it was 
found that sugar elevations of the degree encountered in chronic diabetes af- 
fected phagocytosis only when the leukocytes were operating in crowded exu- 
dates and were ingesting pneumococci with antiphagocytic capsules. 
While the present studies were in progress, Briscoe and Allison (31) reported 
that Type 1 pneumococci were phagocytized and killed just as effectively by 
exudate leukocytes from nonketotic diabetic rats as from normal rats. The re- 
suits, therefore, confirmed the observation that there is no phagocytic defect in 
the diabetic leukocytes. No experiments, however, were included to detect a pos- 
sible defect in the diabetic serum. Because the phagocytic tests were carried out R.  H.  DRACHM.AN,  R.  K.  ROOT,  AND  W.  B.  WOOD,  JR.  237 
in a concentrated cell-pneumococcus system, simulating the conditions of an in 
vivo exudate, it was predicted from the present studies that the addition of hy- 
perglycemic serum, or merely of sufficient glucose, to the system would cause a 
depression of phagocytosis by both normal and diabetic leukocytes. When the 
experiments were performed, the prediction was fully confirmed (Table IX).  n 
The limitations of the glucose effect on phagocytosis raise several interesting 
questions. Why, for example, is phagocytosis not significantly impaired in the 
whole blood of diabetic rats when it is in their peritoneal exudates? Is it merely 
because the  phagocytic system in blood is more dilute  than in most inflam- 
matory exudates,  or do blood granulocytes differ in some way from exudate 
granulocytes? Why also are exudate cells resistant to the depressive effect of 
TABLE IX 
Effect of Added Glucose on Phagocytosis of Type I  Pneumococci in Concentrated 
Systems Studied  by Briscoe and Allison* 
Surface  Medium  Phagocytosls 
Filter paper 
Glass§ 
Serum 
Serum +  glucose:~ 
Saline 
Saline +  glucosel: 
Serum 
Serum +  glucose:~ 
% 
68,  62 
52,  43 
56,  53 
38,  40 
45,  53 
25,  37 
* See reference 31. 
:~ Final concentration of glucose: 750 rag/100 ml. 
§ On glass virtually no phagocytosis (<3%) occurs in isotonic saline, even in the absence 
of added glucose. 
glucose when tested in a phagocytic system containing more serum than is usu- 
ally present in established exudates? Are nonspecific serum opsonins involved, 
or does incubation in the larger volume of serum somehow modify the resistance 
of the cells to the effect of the glucose? Experiments designed to answer these 
questions are now in progress. 
The clinical implications of these studies relate to the importance of control- 
ling hyperglycemia in patients with diabetes meUitus (2). Although most au- 
thorities agree that the objective of insulin therapy is to return the carbohydrate 
metabolism as nearly as possible to normal, some clinicians still contend that 
only ketosis and ketonuria need be avoided (32).  The present results indicate 
n These additional experiments were kindly performed by M. R. Smith, who originally 
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that the severity of an experimental bacterial infection in rats may be signifi- 
cantly enhanced by sustained hyperglycemia. 
SUMMARY 
Chronically diabetic nonketotic rats were shown to be more susceptible to ex- 
perimental Type 25 pneumococcal pneumonia than nondiabetic rats. The cumu- 
lative mortality in the diabetic group was significantly higher at infecting doses 
of 103, 104, 105, and 106 organisms, and the LDso WaS less than one twentieth of 
that for the nondiabefic group. More than ten times as many viable pneumo- 
cocci were found in the pneumonic lesions of the diabetic animals at 24 and 36 
hr as were present in the lesions of the nondiabetic controls, and serial histo- 
logic studies revealed that phagocytosis was strikingly depressed in the alveolar 
exudates of the diabetic animals. The diabetic state was also found to cause a 
similar depression of in vivo phagocytosis in preformed peritoneal exudates. 
The results of in vitro experiments indicated that the principal defect in the 
diabetic animals resided in their serum rather than in their polymorphonuclear 
leukocytes. The depressive factor in the serum was identified as the abnormally 
high concentration of glucose. Since equivalent molar concentrations of uume- 
tabolized sugars added to normal serum caused a similar depression of phago- 
cytosis, it was tentatively concluded that the action of the glucose on the leuko- 
cytes was primarily osmotic. The sensitivity of the granulocytes to the glucose 
effect, however, depended upon the conditions of the phagocytic test. Only when 
the pneumococci were encapsulated and the leukocytes derived from inflam- 
matory exudates were crowded together, as in vivo, was the depressive action 
of the glucose clearly demonstrable. 
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EXPLANATION OF PLATES 
PLATE 17 
FI~.  1.  Comparable histologic sections of 24-hr pneumonic lesions in nondiabetic 
(upper)  and  diabetic  rats  (lower).  Lungs  were  fixed  and  stained  (Gram-Weigert 
method)  as described in reference 15. Photographs  (left to right) are of edema zone, 
zone of early consolidation,  and  zone  of advanced  consolidation,  respectively (16). 
X  844. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  124  PLATE  17 
FIG.  1 
(Drachman et al.: Diabetes and antibacterial defense) PLATX 18 
FIG. 2.  Motility of leukocytes in diabetic (left)  and nondiabetic (right)  serum  as 
indicated by their migration at margin of hanging drop preparations incubated for 30 
rain at 37°C.  The suspensions contained the same concentrations of cells and bacteria 
as in the phagocytic tests (see text). This method of estimating leukocytic motility 
was designed by M.  R.  Smith (25).  X  345  (upper), and  X  776  (lower). TItE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  124  PLATE  18 
FIG. 2 
(Drachman et al.: Diabetes and antibacterial  defense) 